Compare UBER & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UBER | SYK |
|---|---|---|
| Founded | 2009 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.8B | 125.7B |
| IPO Year | 2019 | 1994 |
| Metric | UBER | SYK |
|---|---|---|
| Price | $67.89 | $273.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 51 | 28 |
| Target Price | $100.77 | ★ $369.00 |
| AVG Volume (30 Days) | ★ 15.2M | 2.6M |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.28% |
| EPS Growth | 3.73 | ★ 8.25 |
| EPS | 1.29 | ★ 5.23 |
| Revenue | ★ $52,017,000,000.00 | $25,116,000,000.00 |
| Revenue This Year | $11.30 | $8.42 |
| Revenue Next Year | $15.38 | $8.69 |
| P/E Ratio | $53.90 | ★ $52.92 |
| Revenue Growth | ★ 18.28 | 11.16 |
| 52 Week Low | $65.41 | $267.00 |
| 52 Week High | $101.30 | $392.55 |
| Indicator | UBER | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 37.32 | 37.79 |
| Support Level | $66.45 | $267.00 |
| Resistance Level | $78.60 | $290.51 |
| Average True Range (ATR) | 1.24 | 5.73 |
| MACD | -0.17 | 1.65 |
| Stochastic Oscillator | 19.02 | 34.92 |
Uber is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars and autonomous vehicles, but could eventually support additional products and services, such as drone delivery or electric vertical takeoff and landing (eVTOL) technology. Uber operates in over 70 countries and has over 200 million users who order rides or food at least once a month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.